209 results
8-K
EX-4.2
569ws
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
8-K
EX-4.1
y1sijk55w2aj
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
8-K
EX-99.1
2xb33f32bn8hbxduse
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
UPLOAD
wfm8j98
3 Nov 23
Letter from SEC
12:00am
8-K
EX-10.1
zmrkb
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.3
06hwx
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.1
1m2bdas
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.2
s6u0ob4ytp6tygv10
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
424B5
ycvalzu
2 Oct 23
Prospectus supplement for primary offering
4:52pm
424B5
fh0rfw 7s7mutftd73
21 Jul 23
Prospectus supplement for primary offering
4:39pm